3M2W | Transferase | date | Mar 08, 2010 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Mapkak Kinase 2 (Mk2) Complexed With A Spiroazetidine-Tetracyclic Atp Site Inhibitor | ||||||||||||||
authors | M.Kroemer, L.Revesz, C.Be, A.Izaac, C.Huppertz, A.Schlapbach, C.Sc | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Map Kinase-Activated Protein Kinase 2 Chain: A Fragment: Kinase Domain Synonym: Mapk-Activated Protein Kinase 2, Mapkap Kinase 2, Mk2; Ec: 2.7.11.1 Engineered: Yes Mutation: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Mapkapk2 Expression_system: Escherichia Coli Expression_system_taxid: 562 Expression_system_strain: Bl21(De3)Tuner Expression_system_vector_type: Plasmid Expression_system_plasmid: Pet | ||||||||||||||
symmetry | Space Group: P 63 2 2 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.41 Å | ||||||||||||
ligand | L8I, MG BindingDB | enzyme | Transferase E.C.2.7.11.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II., Revesz L, Schlapbach A, Aichholz R, Dawson J, Feifel R, Hawtin S, Littlewood-Evans A, Koch G, Kroemer M, Mobitz H, Scheufler C, Velcicky J, Huppertz C, Bioorg Med Chem Lett. 2010 Aug 1;20(15):4719-23. Epub 2010 Apr 11. PMID:20591669 |
Data retrieval |
View 3M2W in 3D |
Visual 3D analysis of 3M2W |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3M2W |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |